187 related articles for article (PubMed ID: 15316302)
21. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
Utili R; Rambaldi A; Tripodi MF; Andreana A
Infection; 1995; 23(3):182-3. PubMed ID: 7499009
[TBL] [Abstract][Full Text] [Related]
22. [Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
di Martino L; Gramiccia M; Occorsio P; Di Muccio T; Scalone A; Gradoni L
Parassitologia; 2004 Jun; 46(1-2):221-3. PubMed ID: 15305721
[TBL] [Abstract][Full Text] [Related]
23. [Visceral leishmaniasis in an immunocompetent subject, acquired in the Pyrenees region].
Malvy D; Djossou F; Ibanez C; Vatan R; Longy-Boursier M; Le Bras M
Presse Med; 2006 Jun; 35(6 Pt 1):987-8. PubMed ID: 16783261
[TBL] [Abstract][Full Text] [Related]
24. Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.
Cascio A; Gradoni L; Scarlata F; Gramiccia M; Giordano S; Russo R; Scalone A; Camma C; Titone L
Am J Trop Med Hyg; 1997 Jul; 57(1):75-8. PubMed ID: 9242323
[TBL] [Abstract][Full Text] [Related]
25. An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
Barbosa JF; de Figueiredo SM; Lyon S; Caligiorne RB
Curr Clin Pharmacol; 2016; 11(4):265-269. PubMed ID: 27659611
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of infantile visceral leishmaniasis].
Minodier P; Faraut-Gambarelli F; Piarroux R; Gire C; Garnier JM; Dumon H
Arch Pediatr; 1999 Jan; 6(1):59-66. PubMed ID: 9974099
[TBL] [Abstract][Full Text] [Related]
27. [Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
Piarroux R; Garnier JM; Gambarelli F; Dumon H; Kaplanski S; Unal D
Arch Pediatr; 1996 Apr; 3(4):352-6. PubMed ID: 8762958
[TBL] [Abstract][Full Text] [Related]
28. [Visceral leishmaniasis associated with human immunodeficiency virus infection].
Pintado V; López-Vélez R
Enferm Infecc Microbiol Clin; 2001; 19(7):353-7. PubMed ID: 11747803
[No Abstract] [Full Text] [Related]
29. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic considerations about visceral leishmaniasis. Two case report.
Pasticci MB; Papili R; Menichetti F; Ballanti S; Ottaviani L; Tabilio A; Stagni G
Infez Med; 2002 Sep; 10(3):176-8. PubMed ID: 12704269
[TBL] [Abstract][Full Text] [Related]
31. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
Sayyahfar S; Ansari S; Mohebali M; Behnam B
Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
Borges MM; Pranchevicius MC; Noronha EF; Romero GA; Carranza-Tamayo CO
Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804
[TBL] [Abstract][Full Text] [Related]
33. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
[TBL] [Abstract][Full Text] [Related]
34. Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
Şakru N; Töz SÖ; Korkmaz M; Özbel Y
Turkiye Parazitol Derg; 2011; 35(3):125-8. PubMed ID: 22203498
[TBL] [Abstract][Full Text] [Related]
35. Visceral leishmaniasis treatment, Italy.
Gradoni L; Gramiccia M; Scalone A
Emerg Infect Dis; 2003 Dec; 9(12):1617-20. PubMed ID: 14720406
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Mediterranean visceral leishmaniasis.
Gradoni L; Bryceson A; Desjeux P
Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H
Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498
[TBL] [Abstract][Full Text] [Related]
38. Treatment of visceral leishmaniasis in children with liposomal amphotericin B.
di Martino L; Davidson RN; Giacchino R; Scotti S; Raimondi F; Castagnola E; Tasso L; Cascio A; Gradoni L; Gramiccia M; Pettoello-Mantovani M; Bryceson AD
J Pediatr; 1997 Aug; 131(2):271-7. PubMed ID: 9290615
[TBL] [Abstract][Full Text] [Related]
39. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
Vechi HT; Sousa ASV; Cunha MAD; Shaw JJ; Luz KG
Am J Trop Med Hyg; 2020 Feb; 102(2):268-273. PubMed ID: 31872796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
